Cancer Trials Ireland has worked with the pharmaceutical and CRO industry for many years to bring new trials to Ireland for people with cancer.
To strengthen our capability in supporting feasibility for Industry sponsored cancer clinical trials we have established an exciting new partnership with the Health Research Board Clinical Research Coordination Ireland (HRB CRCI).
HRB CRCI was founded in 2015 to develop the national infrastructure for the conduct of multi-centre clinical trials in all disease and therapeutic areas other than cancer and act as a central point of contact for Industry and Academic Partners including facilitation and support of new trial feasibility requests.
From 1st of April 2019, HRB CRCI will, in collaboration with Cancer Trials Ireland, also manage the feasibility process for Industry sponsored cancer clinical trials.
The purpose of this new partnership with HRB CRCI is to provide a central point of contact and expert service to Industry across all disease and therapeutic areas in Ireland.
As part of this new process Cancer Trials Ireland will continue to review and provide expert advice and opinion on the feasibility of Industry cancer clinical trials. HRB CRCI will liaise directly with Cancer Trials Ireland to ensure all feasibility requests are processed with the aim of maximising success of the trial opening in Ireland.
Each new feasibility will be discussed with Cancer Trials Ireland’s Disease Specific Sub Group (DSSG) Chairs to determine scientific and clinical interest and suitability for adoption into the Cancer Trials Ireland portfolio and individual site feasibility performed. All trials that go through this process will be successfully adopted into the Cancer Trials Ireland portfolio, assigned a Cancer Trials Ireland number and listed on our website when open to accrual.
In future all new feasibility requests from Industry should be submitted to:
Contact: Michele Cunnane, Clinical Trial Liaison Manager
Please include the following information with your request:
• Details of Confidentiality Agreement (CDA) if applicable
• Protocol synopsis/summary and details of the trial’s timelines
• Feasibility survey/questionnaire/survey link
• Timelines for feasibility completion
• Whether trial has been approved for conduct in Ireland or whether currently bidding/seeking approval to open the trial in Ireland
We welcome the opportunity to work with industry partners (Bio-pharmaceutical Companies, CROs and other Collaborative Groups) on new trials and we look forward to working with you and your organisation to bring new cancer trials to Irish patients.
Cancer Trials Ireland will continue to carry out new trial feasibilities for its own In-House trials and for Collaborative group trials independently of HRB CRCI.